IMPDH2 and triple-negative breast carcinoma: Importantly, previous studies have reported a significant increase in apoptosis following IMPDH2 inhibition in cell lines derived from triple-negative breast cancer and diffuse large B-cell lymphoma(Wang et al. 2021; Gao et al. 2023).